Third-Party Review Disclaimer: Customer review data cited in this article was sourced from Trustpilot
It's going to take you a while to ramp up on that GLP-1 to where it's really starting to be effective for weight loss and everything else
It has a Discord community with a health-coaching channel, but its not a structured program
In SURMOUNT-3, 600 participants are randomized to receive either tirzepatide at the maximally tolerated dose or placebo following a structured intensive 12-week lifestyle intervention
Real-world evidence (Nature, 2023) A survey of 153 adults with obesity who were already taking semaglutide or tirzepatide found they reported a 73% reduction in weekly alcohol consumption, and their likelihood of binge-drinking dropped by about 80% compared to similar people not on medication
Tirzepatide, a dual GLP-1 and GIP receptor agonist, has become one of the most effective medications for weight loss since FDA approval in 2023